New ALS Treatment Shows Positive Results in Clinical Trials
Positive results of two Phase 2 clinical trials for a new ALS treatment, CNM-Au8, show significant improvement in biomarkers. CEO expresses optimism about the potential breakthrough.
This news matters as it represents a potential breakthrough in the treatment of ALS, offering hope to patients and their families. The positive results and potential accelerated approval pathway could mean faster access to a new treatment option for those suffering from this devastating disease.
